View in EDS

Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

Saved in:
Bibliographic Details
Title: Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
Authors: Hainsworth JD (AUTHOR), Spigel DR (AUTHOR), Burris HA 3rd (AUTHOR), Shipley D (AUTHOR), Farley C (AUTHOR), Macias-Perez IM (AUTHOR), Barton J (AUTHOR), Greco FA (AUTHOR)
Source: Cancer (0008543X). 5/15/2010, Vol. 116 Issue 10, p2448-2454. 7p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 105192244
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Hainsworth+JD%22">Hainsworth JD</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spigel+DR%22">Spigel DR</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shipley+D%22">Shipley D</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Farley+C%22">Farley C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Macias-Perez+IM%22">Macias-Perez IM</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barton+J%22">Barton J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Greco+FA%22">Greco FA</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+%280008543X%29%22">Cancer (0008543X)</searchLink>. 5/15/2010, Vol. 116 Issue 10, p2448-2454. 7p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=105192244
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.25029
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 2448
    Titles:
      – TitleFull: Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hainsworth JD
      – PersonEntity:
          Name:
            NameFull: Spigel DR
      – PersonEntity:
          Name:
            NameFull: Burris HA 3rd
      – PersonEntity:
          Name:
            NameFull: Shipley D
      – PersonEntity:
          Name:
            NameFull: Farley C
      – PersonEntity:
          Name:
            NameFull: Macias-Perez IM
      – PersonEntity:
          Name:
            NameFull: Barton J
      – PersonEntity:
          Name:
            NameFull: Greco FA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 05
              Text: 5/15/2010
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-print
              Value: 0008543X
          Numbering:
            – Type: volume
              Value: 116
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Cancer (0008543X)
              Type: main
ResultId 1